Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Buttari

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Journal of Neurology|February 18, 2016
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systemsAnna Maria Bargagli, Paola Colais, Nera Agabiti, et al.
Neuroepidemiology|August 10, 2017
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, ItalyPaola Colais, Nera Agabiti, Marina Davoli, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell typesInsha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2013
Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosisFrancesco Mori, Silvia Rossi, Sonia Piccinin, et al.
Plos One|January 7, 2014
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosisSilvia Rossi, Marco Bozzali, Monica Bari, et al.
The Journal of Biological Chemistry|January 26, 2025
Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosisInsha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Journal of Neurochemistry|June 19, 2023
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse modelFrancesco Errico, Luana Gilio, Andrea Mancini, et al.
Biomolecules|February 25, 2022
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple SclerosisFederica Azzolini, Luana Gilio, Luigi Pavone, et al.
Frontiers in Cellular Neuroscience|February 12, 2021
Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple SclerosisAntonio Bruno, Ettore Dolcetti, Francesca Romana Rizzo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 12, 2023
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosisAntonio Bruno, Fabio Buttari, Ettore Dolcetti, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Journal of Neurology|February 18, 2016
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systemsAnna Maria Bargagli, Paola Colais, Nera Agabiti, et al.
Neuroepidemiology|August 10, 2017
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, ItalyPaola Colais, Nera Agabiti, Marina Davoli, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell typesInsha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2013
Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosisFrancesco Mori, Silvia Rossi, Sonia Piccinin, et al.
Plos One|January 7, 2014
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosisSilvia Rossi, Marco Bozzali, Monica Bari, et al.
The Journal of Biological Chemistry|January 26, 2025
Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosisInsha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Journal of Neurochemistry|June 19, 2023
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse modelFrancesco Errico, Luana Gilio, Andrea Mancini, et al.
Biomolecules|February 25, 2022
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple SclerosisFederica Azzolini, Luana Gilio, Luigi Pavone, et al.
Frontiers in Cellular Neuroscience|February 12, 2021
Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple SclerosisAntonio Bruno, Ettore Dolcetti, Francesca Romana Rizzo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 12, 2023
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosisAntonio Bruno, Fabio Buttari, Ettore Dolcetti, et al.
Pageof 14